{
    "id": "0949",
    "question": "A 61-year-old man comes to the emergency department because of a 2-day history of a productive cough and worsening shortness of breath. He has had frequent episodes of a productive cough over the past 3 years. He had smoked 2 packs of cigarettes daily for 30 years but quit 1 year ago. He appears distressed. Pulse oximetry on room air shows an oxygen saturation of 91%. Chest auscultation reveals diffuse wheezes and coarse crackles. A chest x-ray shows increased lung lucency bilaterally and flattening of the diaphragm. Which of the following is the most appropriate initial pharmacotherapy?",
    "options": {
        "A": "Prednisone and albuterol",
        "B": "Albuterol and montelukast",
        "C": "Prednisone and tiotropium",
        "D": "Albuterol and theophylline"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine the most appropriate initial pharmacotherapy for this patient, we need to consider the clinical presentation and the patient's medical history. The patient presents with a productive cough, worsening shortness of breath, and a history of smoking, which are classic symptoms of chronic obstructive pulmonary disease (COPD). The presence of diffuse wheezes and coarse crackles on chest auscultation further supports this diagnosis. The chest x-ray showing increased lung lucency bilaterally and flattening of the diaphragm is also consistent with COPD exacerbation. The patient's oxygen saturation is low at 91% on room air, indicating severe hypoxemia, which is a medical emergency. Given the severity of the patient's symptoms, the initial pharmacotherapy should aim to rapidly improve oxygenation, reduce inflammation, and alleviate bronchospasm. Albuterol is a bronchodilator that is effective in relieving bronchospasm and improving lung function, which is essential in acute COPD exacerbation. However, albuterol alone is not sufficient to address the underlying inflammation and may not be sufficient to improve oxygenation. Prednisone, a corticosteroid, is an anti-inflammatory agent that is commonly used to reduce inflammation in COPD exacerbations. It is the preferred initial treatment for acute exacerbations of COPD, as it has been shown to reduce hospitalization rates and improve lung function. Considering the above, the most appropriate initial pharmacotherapy would be a combination of albuterol and prednisone, as it addresses both the bronchospasm and inflammation. Montelukast is a leukotriene receptor antagonist that is used in chronic management of COPD, but it is not the first-line treatment for acute exacerbations. Tiotropium is an anticholinergic agent that is used in chronic COPD management, but it is not typically used as the initial treatment for acute exacerbations. Theophylline is a methylxanthine that has bronchodilatory properties, but it is not commonly used as a first-line treatment for COPD exacerbations due to its narrow therapeutic index and potential side effects. Therefore, the correct answer is A. Prednisone and albuterol.\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 61.138532638549805
}